CureVac N.V. Reports Q4 and FY 2024 Financial Results
| Field | Detail |
|---|---|
| Company | Curevac N.V. |
| Form Type | 6-K |
| Filed Date | Apr 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, earnings-update, company-news
Related Tickers: CVAC
TL;DR
CureVac (CVAC) dropped its Q4 and FY 2024 earnings report today - check the details.
AI Summary
On April 10, 2025, CureVac N.V. (CVAC) issued a Form 6-K to report its financial results for the fourth quarter and full-year 2024, along with business updates. The filing does not contain specific financial figures but serves as an announcement of the release of this information.
Why It Matters
This filing provides investors with the latest financial performance and operational updates from CureVac N.V., crucial for assessing the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial results announcement and does not contain new material risks.
Key Players & Entities
- CureVac N.V. (company) — Registrant
- April 10, 2025 (date) — Date of press release
- 2024 (date) — Reporting period
- 001-39446 (other) — Commission File Number
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to announce CureVac N.V.'s financial results for the fourth quarter and full-year 2024, along with providing business updates.
When did CureVac N.V. issue the press release announcing these results?
CureVac N.V. issued the press release announcing these results on April 10, 2025.
What is the Commission File Number for CureVac N.V.?
The Commission File Number for CureVac N.V. is 001-39446.
What period do the financial results announced in this filing cover?
The financial results announced in this filing cover the fourth quarter and the full-year 2024.
Does this filing contain the detailed financial figures?
No, this filing (Form 6-K) serves as an announcement of the release of the financial results and business updates, rather than containing the detailed figures themselves.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 10, 2025 regarding CureVac N.V..